CCIA
TWST icon

Campbell & Co Investment Adviser’s Twist Bioscience TWST Stock Holding History

Campbell & Co Investment Adviser’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,200
Closed -$1.33M – 1419
2025
Q3 		$1.33M Buy
47,200
+32,792
+228% +$993K 0.1% 312
2025
Q2 		$530K Buy
+14,408
New +$498K 0.03% 765

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Campbell & Co Investment Adviser's TWST Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 47,200 shares — an estimated $1.33M sold.

Campbell & Co Investment Adviser first reported a position in TWST in Q2 2025 and held it in 2 quarters. The position peaked at $1.33M in Q3 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 47,200 Twist Bioscience shares in Q4 2025, an estimated $1.33M.
  • Campbell & Co Investment Adviser first reported a position in Twist Bioscience in Q2 2025 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Twist Bioscience position peaked at $1.33M in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.